HERPETIC KERATITIS

  • 1 January 1978
    • journal article
    • research article
    • Vol. 17  (10) , 941-957
Abstract
The study on serious clinical problem of herpes infection of the cornea came a long way. There are now effective topical antiviral drugs. There are animal models which, with a high degree of reliability, clearly predict the effect to be expected clinically in man and the toxicity. There are systemically active drugs and the potential of getting highly active, potent, completely selective drugs, with the possibility that perhaps the source of viral reinfection can be eradicated. The biology of recurrent herpes and stromal disease is gradually being understood, and this understanding may result in new and better therapy of this devastating clinical disease.